Subtype
Bone Sarcoma
CI-CAN-00000570Explore in graph →
26 active trials4 approved drugs8 evidence items
- NCIt
- C9312
Loading cancer entity…
Subtype
CI-CAN-00000570Explore in graph →
Clinical trials
88 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (7)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04877587 | Gemcitabine With Ascorbate Including Adolescents | withdrawn | Early Phase 1 | 0 | David DickensOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT05116800 | Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma | withdrawn | Phase 2 | 0 | Brown UniversityOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT04906876 |
| withdrawn |
| Phase 2 |
| 0 |
| Brown UniversityOTHER |
| 1 |
| Jul 28, 2021 |
| clinicaltrials |
| NCT01795430 | Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00334984 | Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma | withdrawn | N/A | 0 | Children's Oncology GroupNETWORK | 0 | Jul 11, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Feb 22, 2023source: clinicaltrials